Cinnamaldehyde attenuates streptozocin-induced diabetic osteoporosis in a rat model by modulating netrin-1/DCC-UNC5B signal transduction.
Cinnamaldehyde (CMD) improves bone strength and structure in diabetic osteoporosis (DOP) rats by inhibiting osteoclast activity through netrin-1/DCC/UNC5B signaling pathway. Relevant for treating bone diseases in diabetic patients.
- Ji S et al (2024).
- Front Pharmacol.
- PubMed:
- 38628640